CRP and soft tissue sarcoma: Previously, a meta-analysis conducted by Li Y et al. [45] reported that higher level of pretreatment CRP level demonstrated a significantly higher risk of decreased recurrence and overall survival rates in both localized bone and soft tissue sarcomas together.